The findings demonstrated that GITR ligation could abrogate the tumor‐infiltrating Tregs‐mediated suppression of effector T cells through treatment with soluble GITR ligand, which was consistent with previous research reports.151, 152, 153. This evidence concerns the gene TNFRSF18 and neoplasm.